AMRI has acquired the Italy-based chemical company, Euticals, in a move that expands its API development and manufacturing business.
Pfizer has attributed Hospira’s sterile injectables and biosimilar assets to its return to growth, offsetting 17 quarters of declining sales.
The new entity will focus on a haemophilia pipeline utilising the XTEN half-life extension technology, bispecific antibodies and gene therapies.
Increased use of generics has put pressure on drug reviewers according to the EDQM which has called for more cross border collaboration and harmonization of regulations.
Colorcon is building a film coating production facility in Indaiatuba, Brazil to service markets in South America.